A Phase IIa Study of NT-KO-003 for Multiple Sclerosis
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01428726 |
|
Recruitment Status :
Completed
First Posted : September 5, 2011
Last Update Posted : March 18, 2014
|
Sponsor:
Neurotec Pharma
Collaborator:
Advancell - Advanced In Vitro Cell Technologies, S.A.
Information provided by (Responsible Party):
Neurotec Pharma
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | January 2014 |
| Actual Study Completion Date : | January 2014 |